Clinical Trials Logo

Clinical Trial Summary

Use of proton pump inhibitors (PPI) has increased in recent years. There are concerns that PPIs have possible negative effects on bone metabolism. It has been suggested that PPIs may reduce the absorption of calcium from the small intestine and lead to bone resorption by affecting osteoclastic activity. In this study, it is planned to investigate the effects of lansoprazole, a proton pump inhibitor, on bone turnover markers in pediatric patients with gastroesophageal reflux or gastroesophageal reflux disease.


Clinical Trial Description

This study is planned to be conducted with children who are diagnosed with gastroesophageal reflux or gastroesophageal reflux disease aged 2-18 years and healthy volunteers. The diagnosis of gastroesophageal reflux will be made in accordance with the guidelines of North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). Written and verbal consent will be obtained from patients/healthy volunteers and/or parents who want to participate in the study. Serum calcium, magnesium, alkaline phosphatase, parathormone, 25-OH vitamin D and osteocalcin and urine calcium, creatinine, deoxypyridinoline, C-terminal telopeptides type-1 collagen and N- terminal telopeptides type-1 collagen levels will be measured at baseline and second month in study group and once in control groups. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04814316
Study type Observational
Source Ataturk University
Contact
Status Completed
Phase
Start date December 2, 2019
Completion date July 1, 2021

See also
  Status Clinical Trial Phase
Completed NCT01139645 - The Effect of Proton Pump Inhibitors on Calcium and Bone Metabolism N/A
Completed NCT01593501 - How Does Magnesium Status Influence Calcium Homeostasis? Phase 4
Recruiting NCT05772364 - High- Versus Low-calcium Water for Bone Health N/A
Completed NCT02778490 - Effects of Sleeve Gastrectomy on Calcium Metabolism and the Skeleton
Completed NCT01209494 - An Arrhythmia Risk Stratification and Genetic Trial N/A